Odyssey Therapeutics
Leadership
Gary D. Glick, Ph.D - Founder, President, & CEO
Founded
2021
Stage Invested
Series D
Backed Since
2025
Status
Private
Lightspeed Team
Dr. Shelley Chu - Partner
Jonathan MacQuitty - Partner
Dr. Brenton Fargnoli - Partner
Ravi Mhatre - Partner & Co-Founder
Odyssey is on a mission to transform the standard of care for patients affected by autoimmune and inflammatory conditions. We target upstream signaling nodes and mechanisms like those in the innate immune system to prevent pathological inflammation before it occurs.
Odyssey Therapeutics
Fraction Fraction

Faction Ventures, L.L.C. ("Faction") and Lightspeed Management Company, L.L.C. ("LSVP") are separate businesses that operate independently of each other. Faction advises its own fund(s) and does not advise any LSVP clients, and LSVP does not advise Faction or any of its clients. LSVP and Faction are parties to an agreement pursuant to which LSVP holds certain interests in Faction and the fund(s) Faction manages.

continue to the Faction Site
INDIA INDIA

Lightspeed Management Company, L.L.C. ("LSVP") and Lightspeed India Partners, L.L.P. ("LSIP") are distinct investment advisory entities, are not a unitary enterprise and operate independently of one another. From time to time LSVP may draw on its relationship with LSIP, and vice versa, but only to the extent consistent with its status as a separate investment adviser.https://lsip.com/

CONTINUE TO LIGHTSPEED INDIA